Desialylation of insulin receptors and IGF-1 receptors by neuraminidase-1 controls the net proliferative response of L6 myoblasts to insulin

Glycobiology

Volumn 20, Issue 5, 2010, Pages 603-616

  Arabkhari, Majid ^a   Bunda, Severa ^a   Wang, Yanting ^a   Wang, Andrew ^a   Pshezhetsky, Alexey V ^b   Hinek, Aleksander ^a,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

IGF 1 receptor; Insulin insulin receptor; Neuraminidase 1; Skeletal myoblasts proliferation

Indexed keywords

INSULIN; INSULIN RECEPTOR; NEURAMINIDASE 1; SIALIDASE; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; MITOSIS INHIBITION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; SIALYLATION;

ANIMALS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; INSULIN; MICE; MYOBLASTS; RATS; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; REPRESSOR PROTEINS; SIALIC ACIDS;

CLOSTRIDIUM PERFRINGENS; RATTUS;

EID: 77952844482     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwq010     Document Type: Article

References (72)

1. Amith SR, Jayanth P, Franchuk S, Finlay T, Seyrantepe V, Beyaert R, Pshezhetsky AV, Szewczuk MR. 2010. Desialylation of sialyl alpha-2, 3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling. Cell Signal. 22(2):314-324.
2. Amoui M, Craddock BP, Miller WT. 2001. Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells. J Endocrinol. 171:153-162.
3. Anastasia L, Papini N, Colazzo F, Palazzolo G, Tringali C, Dileo L, Piccoli M, Conforti E, Sitzia C, Monti E, et al. 2008. NEU3 sialidase strictly modulates GM3 levels in skeletal myoblasts C2C12 thus favoring their differentiation and protecting them from apoptosis. J Biol Chem. 283:36265-36271.
4. Antonescu CN, Randhawa VK, Klip A. 2008. Dissecting GLUT4 traffic components in L6 myocytes by fluorescence-based, single-cell assays. Methods Mol Biol. 457:367-378.
5. Arnqvist HJ. 2008. The role of IGF-system in vascular insulin resistance. Horm Metab Res. 40:588-592.
6. Asakura A, Rudnicki MA. 2002. Cellular and molecular mechanisms regulating skeletal muscle development. Mouse Development.Orlando(FL): Academic. p. 253-278.
7. Bonten EJ, Galjart NJ, Willemsen R, Usmany M, Vlak JM, d'Azzo A. 1995. Lysosomal protective protein/cathepsin A. Role of the "linker" domain in catalytic activation. J Biol Chem. 270:26441-26445.
8. Bonten EJ, d'Azzo A. 2000. Lysosomal neuraminidase. Catalytic activation in insect cells is controlled by the protective protein/cathepsin A. J Biol Chem. 275:37657-37663.
9. Champigny MJ, Perry R, Rudnicki M, Igdoura SA. 2005. Overexpression of MyoD-inducible lysosomal sialidase (neu1) inhibits myogenesis in C2C12 cells. Exp Cell Res. 311:157-166.
10. Charge SB, Rudnicki MA. 2004. Cellular and molecular regulation of muscle regeneration. Physiol Rev. 84:209-238.
11. Chisalita SI, Arnqvist H. 2005. Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells. Diabetologia. 48:2155-2161.
12. D'Agrosa R, Hubbes M, Zhang S, Shankaran R, Callahan J. 1992. Characteristics of the beta-galactosidase-carboxypeptidase complex in GM1-gangliosidosis and beta-galactosialidosis fibroblasts. Biochem J. 285:833-838.
13. Davis TA, Fiorotto ML. 2009. Regulation of muscle growth in neonates. Curr Opin Clin Nutr Metab Care. 12:78-85.
14. d'Azzo A, Andria G, Strisciuglio P, Galjard H. 2001. Metabolic and Molecular Bases of In herited Disease. 8th ed, New York: McGraw-Hill Inc. p. 3811-3826.
15. Decary S, Mouly V, Hamida CB, Sautet A, Barbet JP, Butler-Browne GS. 1997. Replicative potential and telomere length in human skeletal muscle: Implications for satellite cell-mediated gene therapy. Hum Gene Ther. 8:1429-1438.
16. de Geest N, Bonten E, Mann L, de Sousa-Hitzler J, Hahn C, d'Azzo A. 2002. Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. Hum Mol Genet. 11:1455-1464.
17. Duca L, Blanchevoye C, Cantarelli B, Ghoneim C, Dedieu S, Delacoux F, Hornebeck W, Hinek A, Martiny L, Debelle L. 2007. The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 subunit. J Biol Chem. 282:12484-12491.
18. Fanzani A, Giuliani R, Colombo F, Zizioli D, Presta M, Preti A, Marchesini S. 2003. Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells. FEBS Lett. 547:183-188.
19. Fujita-Yamaguchi Y, Sato Y, Kathuria S. 1985. Removal of sialic acids from the purified insulin receptor results in enhanced insulin-binding and kinase activities. Biochem Biophys Res Commun. 129:739-745.
20. Gillespie W, Paulson JC, Kelm S, Pang M, Baum LG. 1993. Regulation of alpha 2, 3-sialyltransferase expression correlates with conversion of peanut agglutinin (PNA)+ to PNAphenotype in developing thymocytes. J Biol Chem. 268:3801-3804.
21. Giraud J, Leshan R, Lee YH, White MF. 2004. Nutrient-dependent and insulinstimulated phosphorylation of insulin receptor substrate-1 on serine 302 correlates with increased insulin signaling. J Biol Chem. 279:3447-3454.
22. Giraud J, Haas M, Feener EP, Copps KD, Dong X, Dunn SL, White MF. 2007. Phosphorylation of Irs1 at SER-522 inhibits insulin signaling. Mol Endocrinol. 21:2294-2302.
23. Le Grand F, Rudnicki MA. 2007. Skeletal muscle satellite cells and adult myogenesis. Curr Opin Cell Biol. 19:628-633.
24. Grounds MD. 1999. Muscle regeneration: Molecular aspects and therapeutic implications. Curr Opin Neurol. 12:535-543.
25. Hatton MWC, Regoeczi E. 1973. A simple method for the purification of commercial neuraminidase preparations free from proteases. Biochim Biophys Acta. 327:114-120.
26. Hawke TJ, Garry DJ. 2001. Myogenic satellite cells: Physiology to molecular biology. J Appl Physiol. 91:534-551.
27. Heidenreich K, Brandenburg D. 1986. Oligosaccharide heterogeneity of insulin receptors. Comparison of N-linked glycosylation of insulin receptors in adipocytes and brain. Endocrinology. 118:1835-1842.
28. Hinek A, Rabinovitch M, Keeley F, Okamura OY, Callahan JW. 1993. The 67kD elastin/laminin-binding protein is related to an enzymatically inactive, alternatively spliced form of beta-galactosidase. J Clin Invest. 91:1198-1205.
29. Hinek A, Pshezhetsky AV, von Itzstein M, Starcher B. 2006. Lysosomal sialidase (neuraminidase-1) is targeted to the cell surface in a multiprotein complex that facilitates elastic fiber assembly. J Biol Chem. 281:3698-3710.
30. Hinek A, Bodnaruk TD, Bunda S, Wang Y, Liu K. 2008. Neuraminidase-1, a subunit of the cell surface elastin receptor, desialylates and functionally inactivates adjacent receptors interacting with the mitogenic growth factors PDGF-BB and IGF-II. Am J Pathol. 173:1042-1056.
31. Igdoura SA, Gafuik C, Mertineit C, Saberi F, Pshezhetsky AV, Potier M, Trasler JM, Gravel RA. 1998. Cloning of the cDNA and gene encoding mouse lysosomal sialidase and correction of sialidase deficiency in human sialidosis and mouse SM/J fibroblasts. Hum Mol Genet. 7:115-121.
32. Itoh K, Takiyama N, Kase R, Kondoh K, Sano A, Oshima A, Sakuraba H, Suzuki Y. 1993. Purification and characterization of human lysosomal protective protein expressed in stably transformed Chinese hamster ovary cells. J Biol Chem. 268:1180-1186.
33. Johansson GS, Arnqvist HJ. 2006. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells. Am J Physiol Endocrinol Metab. 291:E1124-E1130.
34. Kablar B, Asakura A, Krastel K, Ying C, May LL, Goldhamer DJ, Rudnicki MA. 1998. MyoD and Myf-5 define the specification of musculature of distinct embryonic origin. Biochem Cell Biol. 76:1079-1091.
35. Kasuga M, Ezaki O, Akanuma Y, Kosaka K. 1980. Effects of neuraminidase treatment on solubilized insulin receptor. Horm Metab Res. 10:494-496.
36. Klip A, Schertzer JD, Bilan PJ, Thong F, Antonescu C. 2009. Regulation of glucose transporter 4 traffic by energy deprivation from mitochondrial compromise. Acta Physiol (Oxf). 196:27-35.
37. Knibbs RN, Osborner SE, Glick GD, Goldstein IJ. 1993. Binding determinants of the sialic acid-specific lectin from the slug Limax flavus. J Biol Chem. 268:18524-18531.
38. Kuang S, Rudnicki MA. 2008. The emerging biology of satellite cells and their therapeutic potential. Trends Mol Med. 14:82-91.
39. Lescaudron L, Peltekian E, Fontaine-Perus J, Paulin D, Zampieri M, Garcia L, Parrish E. 1999. Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul Disord. 9:72-80.
40. Luo M, Langlais P, Yi Z, Lefort N, De Filippis EA, Hwang H, Christ-Roberts CY, Mandarino LJ. 2007. Phosphorylation of human insulin receptor substrate-1 at serine 629 plays a positive role in insulin signaling. Endocrinology. 148:4895-4905.
41. Miyagi T, Hata K, Hasegawa A, Aoyagi T. 1993. Differential effect of various inhibitors on four types of rat sialidase. Glycoconj J. 10:45-49.
42. Miyagi T, Wada T, Iwamatsu A, Hata K, Yoshikawa Y, Tokuyama S, Sawada M. 1999. Molecular cloning and characterization of a plasma membraneassociated sialidase specific for gangliosides. J Biol Chem. 274:5004-5011.
43. Miyagi T. 2008. Aberrant expression of sialidase and cancer progression. Proc Jpn Acad SerB. 84.
44. Monti E, Preti A, Nesti C, Ballabio A, Borsani G. 1999a. Expression of a novel human sialidase encoded by the NEU2 gene. Glycobiology. 9:1313-1321.
45. Monti E, Preti A, Rossi E, Ballabio A, Borsani G. 1999b. Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases. Genomics. 57:137-143.
46. Monti E, Bassi MT, Papini N, Riboni M, Manzoni M, Venerando B, Croci GL, Preti A, Ballabio A, Tettamanti G, et al. 2000. Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane. Biochem J. 349:343-351.
47. Monti E, Preti A, Venerando B, Borsani G. 2002. Recent development in mammalian sialidase molecular biology. Neurochem Res. 27:649-663.
48. Monti E, Bassi MT, Bresciani R, Civini S, Croci GL, Papini N, Riboni M, Zanchetti G, Ballabio A, Preti A, et al. 2004. Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene family. Genomics. 83:445-453.
49. Neilsen D, Gyllberg H, Ostlund P, Bergman T, Bedecs K. 2004. Increased levels of insulin and insulin-like growth factor-1 hybrid receptors and decreased glycosylation of the insulin receptor alph and beta-subunits in scrapie-infected neuroblastoma N2a cells. Biochem J. 380:571-579.
50. Palmer CM, Rudnicki MA. 2001. The myogenic regulatory factors. Advances in Developmental Biology and Biochemistry. New York: Elsevier Science. 1-32.
51. Palsgaard J, Brown AE, Jensen M, Borup R, Walker M, De Meyts P. 2009. Insulin-like growth factor I (IGF-I) is a more potent regulator of gene expression than insulin in primary human myoblasts and myotubes. Growth Horm IGF Res. 19:168-178.
52. Parise G, O'Reilly CE, Rudnicki MA. 2006. Molecular regulation of myogenic progenitor population. Appl Physiol Nutr Metab. 31:773-781.
53. Pattison S, Pankarican M, Rupar CA, Graham FL, Igdoura SA. 2004. Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression. Hum Mutat. 23:32-39.
54. Privitera S, Prody CA, Callahan JW, Hinek A. 1998. The 67-kDa enzymatically inactive alternatively spliced variant of beta-galactosidase is identical to the elastin/laminin-binding protein. J Biol Chem. 273:6319-6326.
55. Pshezhetsky AV, Potier M. 1996. Association of N-acetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of beta-galactosidase, cathepsin A, and neuraminidase. Possible implication for intralysosomal catabolism of keratan sulfate. J Biol Chem. 271:28359-28365.
56. Pshezhetsky AV, Richard C, Michaud L, Igdoura S, Wang S, Elsliger MA, Qu J, Leclerc D, Gravel R, Dallaire L, et al. 1997. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat Genet. 15:316-320.
57. Saito N, Yu RK. 1995. Biology of Sialic Acids. New York: Plenum Press. p. 261-313.
58. Samokhvalov V, Bilan PJ, Shertzer JD, Antonescu CN, Klip A. 2009. Palmitateand lipopolysaccharide-activated macrophages evoke contrasting insulin responses in muscle cells. Am J Physiol Endocrinol Metab. 296:E37-E46.
59. Sato K, Miyagi T. 1996. Involvement of an endogenous sialidase in skeletal muscle cell differentiation. Biochem Biophys Res Commun. 221:826-830.
60. Schmalbruch H, Lewis DM. 2000. Dynamics of nuclei of muscle fibers and connective tissue cells in normal and denervated rat muscles. Muscle Nerve. 23:617-626.
61. Sasaki A, Hata K, Suzuki S, Sawada M, Wada T, Yamaguchi K, Obinata M, Tateno H, Suzuki H, Miyagi T. 2003. Overexpression of plasma membraneassociated sialidase attenuates insulin signaling in transgenic mice. J Biol Chem. 278:27896-27902.
62. Schultz E, Jaryszak DL, Valliere CR. 1985. Response of satellite cells to focal skeletal muscle injury. Muscle Nerve. 8:217-222.
63. Seyrantepe V, Hinek A, Peng J, Fedjaev M, Ernest S, Kadota Y, Canuel M, Itoh K, Morales CR, Lavoie J, et al. 2008. Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1. Circulation. 117:1973-1981.
64. Seyrantepe V, Iannello A, Liang F, Kanshin E, Jayanth P, Samarani S, Szewczuk MR, Ahmad A, Pshezhetsky AV. 2009. Regulation of phagocytosis in macrophages by the neuraminidase 1 J Biol Chem, Published on line ahead of print, Nov 4.
65. Stamler JS, Meissner G. 2001. Physiology of nitric oxide in skeletal muscle. Physiol Rev. 81:209-237.
66. Suelves M, Lopez-Alemany R, Lluis F, Aniorte G, Serrano E, Parra M, Carmeliet P, Munoz-Canoves P. 2002. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo. Blood. 99:2835-2844.
67. Tsakiridis T, McDowell HE, Walker T, Downes CP, Hundal HS, Vranic M, Klip A. 1995. Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells. Endocrinology. 136:4315-4322.
68. Uemura T, Shiozaki K, Yamaguchi K, Miyazaki S, Satomi S, Kato K, Sakuraba H, Miyagi T. 2009. Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta4. Oncogene. 28:1218-1229.
69. Vinogradova MV, Michaud L, Mezentsev AV, Lukong KE, El-Alfy M, Morales CR, Potier M, Pshezhetsky AV. 1998. Molecular mechanisms of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation. Biochem J. 330:641-650.
70. Wada T, Yoshikawa Y, Tokuyama S, Kuwabara M, Akida H, Miyagi T. 1999. Cloning, expression, and chromosomal mapping of a human ganglioside sialidase. Biochem Biophys Res Commun. 261:21-27.
71. Yamaguchi K, Hata K, Koseki K, Shiozaki K, Akita H, Wada T, Moriya S, Miyagi T. 2005. Evidence for mitochondrial localization of a novel human sialidase (NEU4). Biochem J. 390:85-93.
72. Zanoteli E, Bonten E, van de Vlekkert D, Mann L, d'Azzo A. 2007. The role of neuraminidase 1 in muscle Atrophy. Neuromuscul Disord. 17:896-896.